Literature DB >> 17675245

Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections.

Cihan Top1, Senol Yildiz, Oral Oncül, Tauland Qydedi, Adile Cevikbaş, Umran Gurer Soyogul, Saban Cavuşlu.   

Abstract

AIMS: The aim of this study was to investigate changes in phagocytic activity of neutrophils of type 2 diabetic patients with foot infections over short treatment courses. The potential utility of the phagocytic index in determining the efficacy of treatment modalities and it's relationship with metabolic control parameters were evaluated.
METHODS: The phagocytic activity of neutrophils was determined in blood samples of 38 type 2 diabetic patients with foot infections (14 women and 24 men). Mean age and mean duration of diabetes were 66.3+/-9.4 and 19.1+/-11.2 (yrs), respectively. All patients received standard treatment (intensive insulin therapy, antibiotherapy, hyperbaric oxygen therapy and surgical debridement). Phagocytic activity of neutrophils was determined by a standard method. Phagocytic activity of neutrophils, acute phase proteins (C-reactive protein) and glycosylated haemoglobin was determined before therapy and two weeks later.
RESULTS: The phagocytic index before and after therapy were 47.7+/-11.4 and 62.5+/-15.6, respectively (p<0.05). There was a significant correlation between phagocytic index and both CRP and HbA1c (r=0.52, p<0.05 and r=-0.41, p<0.05, respectively).
CONCLUSIONS: Derangement of carbohydrate metabolism may underlie the impairment of bactericidal activity of neutrophils of poorly controlled diabetic patients. These data reveal that phagocytic activity improves during short-course standard therapy and might enable monitoring of efficacy of treatment modalities in diabetic patients with foot infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675245     DOI: 10.1016/j.jinf.2007.06.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Association of complement C3 and interleukin-1 with foot infections in diabetic patients.

Authors:  Z M H Kheiralla; S S Maklad; S M Ashour; E El-Sayed Moustafa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Dendritic cell modification of neutrophil responses to infection after burn injury.

Authors:  Julia Bohannon; Weihua Cui; Edward Sherwood; Tracy Toliver-Kinsky
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

Review 3.  Potential Advances of Adjunctive Hyperbaric Oxygen Therapy in Infective Endocarditis.

Authors:  Christian Johann Lerche; Franziska Schwartz; Mia Marie Pries-Heje; Emil Loldrup Fosbøl; Kasper Iversen; Peter Østrup Jensen; Niels Høiby; Ole Hyldegaard; Henning Bundgaard; Claus Moser
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

4.  Determinants of Diabetic Peripheral Neuropathy and Their Clinical Significance: A Retrospective Cohort Study.

Authors:  Yifan Cheng; Wen Cao; Junzhe Zhang; Jiabin Wang; Xiang Liu; Qianqian Wu; Qingxia Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

Review 5.  Inpatient management of diabetic foot disorders: a clinical guide.

Authors:  Dane K Wukich; David G Armstrong; Christopher E Attinger; Andrew J M Boulton; Patrick R Burns; Robert G Frykberg; Richard Hellman; Paul J Kim; Benjamin A Lipsky; James C Pile; Michael S Pinzur; Linda Siminerio
Journal:  Diabetes Care       Date:  2013-09       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.